The biotech stage

Join us for TRI's first Biotech Stage on Tuesday 30th August 2022 from 4:00pm-5:00pm. This seminar will focus on the brain, heart and eyes and provides an opportunity to connect, hear latest biomedical advances from our newest tenants at TRI, and inspire Researcher – Clinicians - Industry collaborations.

Hear from our three industry speakers:

• • Mark Smythe, Founder & CEO | Infensa Bioscience: novel drug candidates protecting brain & heart from injury
• • Dr Brenda Castro, Head of Research | Ocugene: next generation retinal therapeutics and gene delivery vectors
• • Stuart Newman, CEO | Therapeutics Innovation Australia: Translating research towards the clinic

Date: Tuesday 30th August 2022
Time: 4:00pm-5:00pm
Location: TRI Auditorium & Zoom
Register: Via Eventbrite